Potential Use of Cefiderocol and Nanosilver in Wound Dressings to Control Multidrug-Resistant Gram-Negative Bacteria
Molecules · 2025
DOI: 10.3390/molecules30153072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Żaneta Binert-Kusztal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Inorganic Chemistry and Pharmaceutical Analytics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9 Street, 30-6…. Hauptthemen laut MEDLINE: Drug Resistance, Multiple, Bacterial, Silver, Anti-Bacterial Agents, Bandages. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jagiellonian University, Jagiellonian University Medical College.
Abstract (Originalsprache)
This study evaluated the antimicrobial efficacy of cefiderocol and various forms of silver (ionic and nanoparticulate) as potential components of wound-dressing reagents against both reference and multidrug-resistant (MDR) Gram-negative bacteria. The anticipated synergistic effect between cefiderocol and nanosilver was not consistently observed; in fact, for reference strains, the combination was less effective than cefiderocol alone. However, in MDR and cefiderocol-resistant A. baumannii strains, combining both agents enhanced antibacterial efficacy. Notably, the effectiveness of silver did not increase with concentration, and low or medium nanosilver concentrations were often more effective. Mechanistically, high concentrations of silver may antagonize cefiderocol’s action by inhibiting bacterial surface proteins involved in siderophore-mediated uptake. Generalized linear modeling confirmed that the strain type, silver form, concentration, and their interactions significantly influenced inhibition zones. These findings highlight the importance of agent selection, concentration, and formulation in designing effective antimicrobial wound dressings. They also suggest that further research is needed to optimize such combination therapies for clinical use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Inorganic Chemistry and Pharmaceutical Analytics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9 Street, 30-688 Krakow, Poland.
- AGH University of Krakow, Department of Analytical Chemistry and Biochemistry, Faculty of Materials Science and Ceramics, Al. Mickiewicza 30, 30-059 Krakow, Poland.
- Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9 Street, 30-688 Krakow, Poland.
- Department of Microbiology, University Hospital, Marii Orwid 11 Street, 30-680 Krakow, Poland.
- AGH University of Krakow, Faculty of Non-Ferrous Metals, al. Mickiewicza 30, 30-059 Krakow, Poland.
- Biotechnology Centre, Silesian University of Technology, Krzywoustego 8 Street, 44-100 Gliwice, Poland.
ORCID-Profile: Agata Krakowska, Iwona Skiba-Kurek, Magdalena Luty-Błocho, Anna Kula, Przemysław Dorożyński, Tomasz Skalski
Förderung
- Jagiellonian University
- Jagiellonian University Medical College
Zitieren
APA
Binert-Kusztal, Ż., Krakowska, A., Skiba-Kurek, I., Luty-Błocho, M., Kula, A., Olechowska-Jarząb, A., Dorożyński, P., & Skalski, T. (2025). Potential Use of Cefiderocol and Nanosilver in Wound Dressings to Control Multidrug-Resistant Gram-Negative Bacteria. Molecules. https://doi.org/10.3390/molecules30153072
Vancouver
Binert-Kusztal Ż, Krakowska A, Skiba-Kurek I, Luty-Błocho M, Kula A, Olechowska-Jarząb A, et al. Potential Use of Cefiderocol and Nanosilver in Wound Dressings to Control Multidrug-Resistant Gram-Negative Bacteria. Molecules. 2025. doi:10.3390/molecules30153072
BibTeX
@article{BinertKusztal2025,
author = {Binert-Kusztal, Żaneta and Krakowska, Agata and Skiba-Kurek, Iwona and Luty-Błocho, Magdalena and Kula, Anna and Olechowska-Jarząb, Aldona and Dorożyński, Przemysław and Skalski, Tomasz},
title = {Potential Use of Cefiderocol and Nanosilver in Wound Dressings to Control Multidrug-Resistant Gram-Negative Bacteria},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30153072}
}
EUVIMED